We are building this new website to better deliver information. Find out more. We are building this new website to better deliver information. Find out more.
Let us know what you think.

Updates on 20/09/2019

After vaccination

Section on reporting to immunisation registers updated to reflect closure of National HPV Vaccination Program Register.

Catch-up vaccination

Section on assessing immunisation status updated to reflect closure of National HPV Vaccination Program Register.

Principles of catch-up vaccination updated to provide more detailed guidance on concomitant and sequential administration of vaccines.

Diphtheria

Guidance under Co-administration with other vaccines updated.

View Diphtheria

Haemophilus influenzae type b (Hib)

Guidance under Co-administration with other vaccines updated.

Hepatitis B

Guidance on co-administration of hepatitis B-containing vaccines with quadrivalent meningococcal vaccines has been added.

Information about the seroconversion rate after a standard 3-dose schedule has been added.

Influenza (flu)

Wording of recommendation for preterm infants updated to include recommended age for vaccination.

Recommendation for people travelling in the influenza season updated to include more specific guidance on vaccinating returning travellers who have received the Northern Hemisphere vaccine.

Guidance under Co-administration with other vaccines updated.

Measles

Editorial update of guidance on the age at 1st MMR dose for children, to correct typographical error.

Recommendation for travellers updated to provide more information about the age group of travellers who require 2 doses of MMR vaccine.

Guidance under Co-administration with other vaccines updated.

Nature of the disease section updated to define the prodromal period.

Vaccine information section updated to clarify WHO vaccine effectiveness estimate.

View Measles

Meningococcal disease

Recommendations and Variations from product information updated to include advice on use of Menveo in infants travelling to areas with high meningococcal A activity.

Guidance under Co-administration with other vaccines updated.

Pertussis (whooping cough)

Guidance under Co-administration with other vaccines updated.

Guidance on timing of vaccination for women who did not receive pertussis vaccine during pregnancy updated.

Pneumococcal disease

Recommendations for people with medical risk factors updated to provide greater clarity on the number and timing of 23vPPV doses.

Guidance under Co-administration with other vaccines updated.

Poliomyelitis

Guidance on Co-administration with other vaccines added.

Preparing for vaccination

Pre-vaccination screening section updated to include guidance on appropriate spacing of inactivated and live parenteral vaccines.

Rotavirus

Guidance on administration of rotavirus vaccine to infants exposed to bDMARDs in utero updated.

View Rotavirus

Tetanus

Guidance under Co-administration with other vaccines updated.

View Tetanus

Vaccination for international travellers

Guidance on vaccination of travellers against measles, mumps and rubella updated to reflect advice in the Measles chapter.

Vaccination for people who are immunocompromised

Editorial changes to 'Table. Recommended timing of live vaccine doses in adults and children taking corticosteroids' in the ‘Use of live vaccines in people who are immunocompromised' section, to correct prednisone-equivalent doses for children and adolescents aged <16 years who weigh >10 kg.

Guidance on assessing the level of immunocompromise in children and adults with HIV updated.

Guidance on vaccination of infants born to mothers who received bDMARDs during pregnancy updated.

Vaccination for women who are planning pregnancy, pregnant or breastfeeding

Guidance on vaccination of infants born to mothers who received bDMARDs during pregnancy updated.

Yellow fever

Guidance on international travel requirements updated.

Contraindications for people who are immunocompromised updated.

Editorial change in Adverse events section to correct placement of references for the rate of immediate hypersensitivity reactions after yellow fever vaccination.

Guidance on risk to travellers updated.